Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension
Oleg Pak, Susan Scheibe, Azadeh Esfandiary, Mareike Gierhardt, Akylbek Sydykov, Angela Logan, Athanasios Fysikopoulos, Florian Veit, Matthias Hecker, Florian Kroschel, Karin Quanz, Alexandra Erb, Katharina Schäfer, Mirja Fassbinder, Nasim Alebrahimdehkordi, Hossein A. Ghofrani, Ralph T. Schermuly, Ralf P. Brandes, Werner Seeger, Michael P. Murphy, Norbert Weissmann, Natascha Sommer
Source: Eur Respir J, 51 (3) 1701024; 10.1183/13993003.01024-2017
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Oleg Pak, Susan Scheibe, Azadeh Esfandiary, Mareike Gierhardt, Akylbek Sydykov, Angela Logan, Athanasios Fysikopoulos, Florian Veit, Matthias Hecker, Florian Kroschel, Karin Quanz, Alexandra Erb, Katharina Schäfer, Mirja Fassbinder, Nasim Alebrahimdehkordi, Hossein A. Ghofrani, Ralph T. Schermuly, Ralf P. Brandes, Werner Seeger, Michael P. Murphy, Norbert Weissmann, Natascha Sommer. Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension. Eur Respir J, 51 (3) 1701024; 10.1183/13993003.01024-2017
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: